SCLC-I tumors showed elevated transcriptional levels of immune genes, suggestive the presence of infiltrating immune cells, but also low expression of the SCLC subtype markers of ASCL1, NEUROD1, and POU2F3. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.